- /
- Supported exchanges
- / US
- / SOPH.NASDAQ
Sophia Genetics SA (SOPH NASDAQ) stock market data APIs
Sophia Genetics SA Financial Data Overview
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sophia Genetics SA (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sophia Genetics SA data using free add-ons & libraries
Get Sophia Genetics SA Fundamental Data
Sophia Genetics SA Fundamental data includes:
- Net Revenue: 81 180 K
- EBITDA: -70 322 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-12
- EPS/Forecast: -0.225
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sophia Genetics SA News
New
SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary
SOPHiA GENETICS S.A. Q1 2026 Earnings Call Summary - Moby Strategic Performance and Market Dynamics Management attributes the 22% revenue growth to a global shift toward decentralized testing, parti...
SOPHiA Genetics (SOPH) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATE Tuesday, May 5, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Jurgi Camblong Chief Financial Officer — George Cardoza Chief Executive Office...
BTIG Raises its Price Target on SOPHiA GENETICS (SOPH) to $8
SOPHiA GENETICS SA (NASDAQ:SOPH) is one of the 8 Best Healthcare AI Stocks to Buy According to Analysts. On April 15, 2026, BTIG raised its price target on SOPHiA GENETICS SA (NASDAQ:SOPH) to $8 fro...
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?
Tempus AI, Inc. TEM is expected to report first-quarter 2026 results on May 5, after market close. In the last reported quarter, the company’s adjusted loss of 4 cents per share was broader than th...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.